安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- BridgeBio | Biotechnology Company | Designing Transformative Medicines
BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers
- About Us - BridgeBio
BridgeBio's mission is to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers
- Our Science Pipeline - BridgeBio
BridgeBio ultimately exists to help patients We are committed to discover, create, test, and deliver breakthrough medicines for genetic diseases to patients as quickly and safely as possible
- Careers - BridgeBio
We’re always on the lookout for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity Join the BridgeBio team!
- News - BridgeBio
Catch up on news from BridgeBio and our pipeline developments Follow us on LinkedIn, Twitter, and Facebook to keep up with all of the latest news
- BridgeBio Pharma Inc. - Investor Relations
BridgeBio Pharma, Inc (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials
- BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of . . .
Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors
- BridgeBio Announces Progress in Many Areas | BridgeBio
BridgeBio will announce BridgeBioX, the company’s new early research discovery engine with a dedicated lab at Stanford University BridgeBio created BridgeBioX to test earlier scientific hypotheses in discovery research and target large, complex genetic diseases with high unmet need
|
|
|